Literature DB >> 14528055

Role for the ubiquitin-proteasome system in Parkinson's disease and other neurodegenerative brain amyloidoses.

Darren J Moore1, Valina L Dawson, Ted M Dawson.   

Abstract

Many neurodegenerative brain amyloidoses, including Alzheimer's and Parkinson's disease, are characterized by selective neuronal loss together with the appearance of intraneuronal ubiquitin-positive proteinaceous aggregates or inclusion bodies. These features usually result from the abnormal accumulation and processing of mutant, misfolded, or damaged intracellular proteins. It has recently become clear that both genetic factors and aberrant proteolytic degradation may therefore play a major role in neuronal degeneration. Indeed, the linkage of two genes directly involved in the ubiquitin-proteasome system (UPS) in familial Parkinson's disease clearly indicates a central role for the UPS in neurodegeneration, and thus Parkinson's disease is considered the prototypical disorder associated with UPS dysfunction. In this review, we provide an overview of the key genes/proteins implicated in the abnormal UPS-mediated proteolytic processing of unwanted proteins observed in neurodegenerative brain amyloidoses. We also provide an outline of the various components and pathways involved in the normal cellular functioning of the UPS and discuss the mechanisms by which UPS dysfunction can compromise neuronal integrity. A more complete understanding of the UPS and its relationship to the neurodegenerative process will undoubtedly provide tremendous insight into the molecular pathogenesis of amyloidogenic neurodegenerative disorders and will allow the development of novel rational therapies for treating these disorders.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14528055     DOI: 10.1385/NMM:4:1-2:95

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   4.103


  98 in total

Review 1.  Alpha-synuclein and neurodegenerative diseases.

Authors:  M Goedert
Journal:  Nat Rev Neurosci       Date:  2001-07       Impact factor: 34.870

2.  The ubiquitin pathway in Parkinson's disease.

Authors:  E Leroy; R Boyer; G Auburger; B Leube; G Ulm; E Mezey; G Harta; M J Brownstein; S Jonnalagada; T Chernova; A Dehejia; C Lavedan; T Gasser; P J Steinbach; K D Wilkinson; M H Polymeropoulos
Journal:  Nature       Date:  1998-10-01       Impact factor: 49.962

Review 3.  Parkin and Parkinson's disease.

Authors:  Y Mizuno; N Hattori; H Mori; T Suzuki; K Tanaka
Journal:  Curr Opin Neurol       Date:  2001-08       Impact factor: 5.710

4.  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

Authors:  M H Polymeropoulos; C Lavedan; E Leroy; S E Ide; A Dehejia; A Dutra; B Pike; H Root; J Rubenstein; R Boyer; E S Stenroos; S Chandrasekharappa; A Athanassiadou; T Papapetropoulos; W G Johnson; A M Lazzarini; R C Duvoisin; G Di Iorio; L I Golbe; R L Nussbaum
Journal:  Science       Date:  1997-06-27       Impact factor: 47.728

5.  Association between a polymorphism of ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) gene and sporadic Parkinson's disease.

Authors: 
Journal:  Parkinsonism Relat Disord       Date:  2000-10-01       Impact factor: 4.891

6.  Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1.

Authors:  Y Zhang; J Gao; K K Chung; H Huang; V L Dawson; T M Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

7.  Ubiquitin carboxyl-terminal hydrolase (PGP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases.

Authors:  J Lowe; H McDermott; M Landon; R J Mayer; K D Wilkinson
Journal:  J Pathol       Date:  1990-06       Impact factor: 7.996

8.  Synphilin-1 is present in Lewy bodies in Parkinson's disease.

Authors:  K Wakabayashi; S Engelender; M Yoshimoto; S Tsuji; C A Ross; H Takahashi
Journal:  Ann Neurol       Date:  2000-04       Impact factor: 10.422

9.  Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism.

Authors:  Vincenzo Bonifati; Patrizia Rizzu; Marijke J van Baren; Onno Schaap; Guido J Breedveld; Elmar Krieger; Marieke C J Dekker; Ferdinando Squitieri; Pablo Ibanez; Marijke Joosse; Jeroen W van Dongen; Nicola Vanacore; John C van Swieten; Alexis Brice; Giuseppe Meco; Cornelia M van Duijn; Ben A Oostra; Peter Heutink
Journal:  Science       Date:  2002-11-21       Impact factor: 47.728

10.  Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice.

Authors:  Michael K Lee; Wanda Stirling; Yanqun Xu; Xueying Xu; Dike Qui; Allen S Mandir; Ted M Dawson; Neal G Copeland; Nancy A Jenkins; Don L Price
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-25       Impact factor: 11.205

View more
  19 in total

1.  Parkin mediates the degradation-independent ubiquitination of Hsp70.

Authors:  Darren J Moore; Andrew B West; Dustin A Dikeman; Valina L Dawson; Ted M Dawson
Journal:  J Neurochem       Date:  2008-02-01       Impact factor: 5.372

Review 2.  The ubiquitin-proteasome system in myocardial ischaemia and preconditioning.

Authors:  Saul R Powell; Andras Divald
Journal:  Cardiovasc Res       Date:  2009-09-30       Impact factor: 10.787

Review 3.  Ubiquitin/proteasome pathway impairment in neurodegeneration: therapeutic implications.

Authors:  Qian Huang; Maria E Figueiredo-Pereira
Journal:  Apoptosis       Date:  2010-11       Impact factor: 4.677

Review 4.  Life and death in the trash heap: The ubiquitin proteasome pathway and UCHL1 in brain aging, neurodegenerative disease and cerebral Ischemia.

Authors:  Steven H Graham; Hao Liu
Journal:  Ageing Res Rev       Date:  2016-10-01       Impact factor: 10.895

5.  Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration.

Authors:  Wanli W Smith; Zhong Pei; Haibing Jiang; Darren J Moore; Yideng Liang; Andrew B West; Valina L Dawson; Ted M Dawson; Christopher A Ross
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-13       Impact factor: 11.205

Review 6.  Mechanisms of selective autophagy and mitophagy: Implications for neurodegenerative diseases.

Authors:  Charleen T Chu
Journal:  Neurobiol Dis       Date:  2018-07-17       Impact factor: 5.996

7.  A system-based comparison of gene expression reveals alterations in oxidative stress, disruption of ubiquitin-proteasome system and altered cell cycle regulation after exposure to cadmium and methylmercury in mouse embryonic fibroblast.

Authors:  Xiaozhong Yu; Joshua F Robinson; Jaspreet S Sidhu; Sungwoo Hong; Elaine M Faustman
Journal:  Toxicol Sci       Date:  2010-01-08       Impact factor: 4.849

8.  Alpha-synuclein aggregation, Ubiquitin proteasome system impairment, and L-Dopa response in zinc-induced Parkinsonism: resemblance to sporadic Parkinson's disease.

Authors:  Vinod Kumar; Deepali Singh; Brajesh Kumar Singh; Shweta Singh; Namrata Mittra; Rakesh Roshan Jha; Devendra Kumar Patel; Chetna Singh
Journal:  Mol Cell Biochem       Date:  2017-12-02       Impact factor: 3.396

9.  Illicit stimulant use is associated with abnormal substantia nigra morphology in humans.

Authors:  Gabrielle Todd; Carolyn Noyes; Stanley C Flavel; Chris B Della Vedova; Peter Spyropoulos; Barry Chatterton; Daniela Berg; Jason M White
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

Review 10.  Molecular aspects of dopaminergic neurodegeneration: gene-environment interaction in parkin dysfunction.

Authors:  Syed F Ali; Zbigniew K Binienda; Syed Z Imam
Journal:  Int J Environ Res Public Health       Date:  2011-12-16       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.